US Archives - Page 56 of 112 - European Medical Journal

Cost-Effective Tactics Improve Measles Vaccine Uptake

A recent systematic review and meta-analysis has identified several effective and cost-efficient strategies to enhance measles vaccination coverage and timeliness in low-income and middle-income countries (LMICs).

New Research in Pulmonary Fibrosis Could Reverse Lung Scarring

Pulmonary fibrosis (PF), a severe form of lung disease, often leads to irreversible lung damage, and macrophages play a critical role in its progression.

GERD Symptoms Linked to Worse RA Outcomes

Gastroesophageal (GE) symptoms, such as acid reflux and heartburn, are significantly associated with higher disease activity in patients with rheumatoid arthritis (RA), according to a new study.

Hidradenitis Suppurativa Long-Term Data Shows Lasting Relief

Long-term data reveal that bimekizumab, a dual IL-17A and IL-17F inhibitor, provides sustained symptom control for patients with hidradenitis suppurativa (HS).

What Do Brain Oscillations Tell Us About Epilepsy in Alzheimer’s?

High-frequency oscillations (HFOs) as potential biomarkers in Alzheimer’s disease (AD), have been highlighted in a new study, offering insight into how epilepsy affects neurodegeneration.

Long-Term Study on Effects of IVF on Cancer Risk

A long-term study of assisted reproductive technology (ART) has found no increased risk of endometrial cancer, addressing concerns about the potential long-term effects of fertility treatments.

A Roadmap for Clear Skin

Notable recent additions to dermatologists’ acne toolkit include newer dual and triple combination therapies, as well as agents with…

AMJ Dermatology 2 [Supplement 1] 2025

Notable recent additions to dermatologists’ acne toolkit include newer dual and triple combination therapies, as well as agents with…

New Clinical Guidelines for Managing Central Airway Obstruction

Clinical practice guidelines providing critical recommendations for managing central airway obstruction (CAO), a condition linked to poor prognosis in both malignant and nonmalignant airway diseases, have recently been published.

What Are Best Next Steps After JAKi Failure?

For patients with rheumatoid arthritis (RA) with an inadequate response to Janus kinase inhibitors (JAKi), new research suggests that cycling to another JAKi may be more effective than switching to a biologic disease-modifying anti-rheumatic drug (bDMARD).